Veterinary Medicines

NEOSKILAB Solution for injection

Authorised
  • NEOSTIGMINE METHYLSULFATE
Download as PDF

Product identification

Medicine name:
NEOSKILAB 1.5 mg/ml solution for injection for cattle, sheep, goats and horses
NEOSKILAB Solution for injection
Active substance:
  • NEOSTIGMINE METHYLSULFATE
Target species:
  • Cattle
  • Sheep
  • Goat
  • Horse
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • NEOSTIGMINE METHYLSULFATE
    1.50
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Sheep
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Goat
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Horse
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
  • Subcutaneous use
    • Cattle
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Sheep
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Goat
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Horse
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN07AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • box containing 1 vial of 25 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Labiana Life Sciences S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Labiana Life Sciences S.A.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10402/004/001
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0389/001
Concerned member states:
  • Belgium
  • Croatia
  • Cyprus
  • Estonia
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Portugal
  • Romania

Documents

Summary of Product Characteristics

English (PDF)
Published on: 12/04/2023
Download

Combined File of all Documents

English (PDF)
Published on: 3/12/2025
Download